company background image
300791 logo

Sirio Pharma SZSE:300791 Stock Report

Last Price

CN¥27.37

Market Cap

CN¥6.4b

7D

-1.2%

1Y

35.0%

Updated

20 Oct, 2024

Data

Company Financials +

Sirio Pharma Co., Ltd.

SZSE:300791 Stock Report

Market Cap: CN¥6.4b

Sirio Pharma Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Sirio Pharma
Historical stock prices
Current Share PriceCN¥27.37
52 Week HighCN¥35.48
52 Week LowCN¥19.15
Beta0.81
11 Month Change13.33%
3 Month Change19.62%
1 Year Change35.03%
33 Year Change-9.37%
5 Year Change20.10%
Change since IPO1.58%

Recent News & Updates

Is Now The Time To Put Sirio Pharma (SZSE:300791) On Your Watchlist?

Oct 14
Is Now The Time To Put Sirio Pharma (SZSE:300791) On Your Watchlist?

The Market Lifts Sirio Pharma Co., Ltd. (SZSE:300791) Shares 27% But It Can Do More

Sep 30
The Market Lifts Sirio Pharma Co., Ltd. (SZSE:300791) Shares 27% But It Can Do More

Is Sirio Pharma (SZSE:300791) Using Too Much Debt?

Sep 23
Is Sirio Pharma (SZSE:300791) Using Too Much Debt?

Recent updates

Is Now The Time To Put Sirio Pharma (SZSE:300791) On Your Watchlist?

Oct 14
Is Now The Time To Put Sirio Pharma (SZSE:300791) On Your Watchlist?

The Market Lifts Sirio Pharma Co., Ltd. (SZSE:300791) Shares 27% But It Can Do More

Sep 30
The Market Lifts Sirio Pharma Co., Ltd. (SZSE:300791) Shares 27% But It Can Do More

Is Sirio Pharma (SZSE:300791) Using Too Much Debt?

Sep 23
Is Sirio Pharma (SZSE:300791) Using Too Much Debt?

Sirio Pharma Co., Ltd.'s (SZSE:300791) Prospects Need A Boost To Lift Shares

Aug 01
Sirio Pharma Co., Ltd.'s (SZSE:300791) Prospects Need A Boost To Lift Shares

Sirio Pharma (SZSE:300791) Will Be Hoping To Turn Its Returns On Capital Around

Jun 30
Sirio Pharma (SZSE:300791) Will Be Hoping To Turn Its Returns On Capital Around

Is Sirio Pharma (SZSE:300791) A Risky Investment?

Jun 12
Is Sirio Pharma (SZSE:300791) A Risky Investment?

An Intrinsic Calculation For Sirio Pharma Co., Ltd. (SZSE:300791) Suggests It's 24% Undervalued

Apr 24
An Intrinsic Calculation For Sirio Pharma Co., Ltd. (SZSE:300791) Suggests It's 24% Undervalued

Sirio Pharma (SZSE:300791) Seems To Use Debt Quite Sensibly

Mar 06
Sirio Pharma (SZSE:300791) Seems To Use Debt Quite Sensibly

Shareholder Returns

300791CN Personal ProductsCN Market
7D-1.2%-1.1%2.7%
1Y35.0%-14.1%4.6%

Return vs Industry: 300791 exceeded the CN Personal Products industry which returned -14.1% over the past year.

Return vs Market: 300791 exceeded the CN Market which returned 4.6% over the past year.

Price Volatility

Is 300791's price volatile compared to industry and market?
300791 volatility
300791 Average Weekly Movement8.6%
Personal Products Industry Average Movement7.2%
Market Average Movement7.6%
10% most volatile stocks in CN Market11.5%
10% least volatile stocks in CN Market5.3%

Stable Share Price: 300791 has not had significant price volatility in the past 3 months compared to the CN market.

Volatility Over Time: 300791's weekly volatility (9%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19932,610Peiqing Liwww.siriopharma.com

Sirio Pharma Co., Ltd. operates as a contract manufacturer for dietary supplement industry worldwide. The company develops and manufactures a range of softgel dietary supplements; vegetarian softgel; nutraceutical gummies; probiotic products; tablet and powder products; capsules; and functional beverages. It also offers a range of services, including primary and final packaging.

Sirio Pharma Co., Ltd. Fundamentals Summary

How do Sirio Pharma's earnings and revenue compare to its market cap?
300791 fundamental statistics
Market capCN¥6.41b
Earnings (TTM)CN¥334.33m
Revenue (TTM)CN¥4.03b

19.2x

P/E Ratio

1.6x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
300791 income statement (TTM)
RevenueCN¥4.03b
Cost of RevenueCN¥2.77b
Gross ProfitCN¥1.26b
Other ExpensesCN¥922.70m
EarningsCN¥334.33m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

Oct 24, 2024

Earnings per share (EPS)1.43
Gross Margin31.21%
Net Profit Margin8.30%
Debt/Equity Ratio47.2%

How did 300791 perform over the long term?

See historical performance and comparison

Dividends

3.1%

Current Dividend Yield

59%

Payout Ratio